• Welcome to Phoenix Rising!

    Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of, and finding treatments for, complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia, long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.

    To become a member, simply click the Register button at the top right.

Lancet publishes study on SIM01 in long covid

consuegra

Senior Member
Messages
178
What interests me is the micro-encapsulation of three bifidobacterium and claims that these items reach the gut and colonize. I wonder if this is true? This Lancet publication of this Chinese study gives some specific credibility to SIM01. This formulation of SIM01 seems slightly different than other probiotics, especially Bifidobacteria products. Being able to raise Bifidobacteria in the gut is notoriously difficult. Seems a big deal if this would work. I suppose the best way to find out is to give it a try.

Chris
 

consuegra

Senior Member
Messages
178
From the Lancet publication

"The synbiotic preparation (SIM01) is a micro-encapsulated lyophilised powder containing 20 billion colony-forming units of three bacterial strains, B adolescentis, Bifidobacterium bifidum, and Bifidobacterium longum with three prebiotic compounds including galacto-oligosaccharides, xylo-oligosaccharides, and resistant dextrin, which has been shown to promote the growth of these bacterial strains but also other probiotic strains.

The specific ratio of the three probiotic bacteria was decided based on the relative abundance of these species naturally present in the healthy Chinese population. We previously found that the relative abundance of several species, including B adolescentis and B longum, and the bacterial pathway of short-chain fatty acid production, were all significantly lower in the gut of COVID-19 patients compared with healthy individuals."

The key seems to be the micro-encapsulated lyophilized powder. Bifodobactium species seem to be somewhat predictable.

If this raises bifidcobacterium in gut, that would be helpful

Chris
 

godlovesatrier

Senior Member
Messages
2,554
Location
United Kingdom
Depends on the strains used I haven't seen them mention that in the study paper myself. Just the species used, not the strains. So without taht info it's anyone's guess to be honest.

Life extension do https://www.lifeextensioneurope.co.uk/bifido-gi-balance which is longum bb536

Another very good longum branded probiotic: https://uk.iherb.com/pr/align-probi...k6ogGkz5ugR3pIEpaOIW_bJWFbjTQ0cPGTUwFDnd2IraM

https://www.metabolics.com/bifidobacterium-longum-powder-100g.html

These 3 are all excellent brands and all mention the strain used which is important.

Struggling to find bifidobacterium adolescentis

I found this though which contains a strain of longum and adlescentis: https://uk.iherb.com/pr/nb-pure-poobiotics-60-capsules/120599 but can't tell you if the brand is any good.

Probiotic Blend (10 Billion cfu**)
lactobacillus acidophilus DDS-1®, Bifidobacterium
bifidum UAB-b-10™, Bifidobacterium adolescentis iVS-1®
Bifidobacterium lactis UABla-12™, Bifidobacterium
longum iVE-15®

Never seen these strains before myself.

ive-15 claims (no scientific studies seem to back this up)
  • When delivered as a synbiotic with XOS, iVE-15® was able to establish a desirable presence in 18 out of 20 fecal microbiome samples tested​

  • iVE-15® achieves a very high (90%) colonization rate​

  • Superior consumer of prebiotic XOS​

I don't tolerate these fancy strains of any sort or type, I've tried about 8 now and had bad results throughout, most give me insomnia, others give me bad acid reflux (possible comorbidity for many pwme), but I am sure some of you who have better tolerance may do well on them :)


I do think if I had got on these products earlier in my ME things would have been much different. I think there's a lot of damage in my body which may or may not lift with cessation of viral and bacterial load replication.
 

Forummember9922

Senior Member
Messages
166
Infantis is used by the Remission Biome people, and some other articles below
https://cfsremission.com/2013/08/14/bifidobacterium-infantis-35624-a-demonstrated-probiotic/
https://www.tandfonline.com/doi/full/10.4161/gmic.25487

I think a lot of people will now want to try G-Niib Sim01.
For people like myself in the USA I dont see a clear way to buy this right now

But- It was recently listed on Amazon UK so maybe that's worth watching.
https://www.amazon.co.uk/G-NiiB-Immunity-microbiome-Resistant-Polydextrose/dp/B0CKWH68C6


Personally I was thinking of incorporating something like this until I can get G-Niib
https://www.amazon.com/Garden-Life-Formulated-Probiotics-Postbiotics/dp/B09TG538V8
 
Last edited:

Atlas

"And the last enemy to be destroyed is death."
Messages
120
Location
New Zealand
Depends on the strains used I haven't seen them mention that in the study paper myself. Just the species used, not the strains.

They are "gut microbiota-derived" strains, that is, they are naturally occurring strains in the gut, which were chosen for this new formula on the basis of an AI analysis of the microbiome of people from China, which had the goal of finding strains which are beneficial regulators of the microbiome.

The species were B adolescentis, Bifidobacterium bifidum, and Bifidobacterium longum. It is not clear how they chose the exact strains of these species, since the strains would surely differ slightly amongst and even within individuals. It appears likely by my reading that the AI analysis must have been based on the species-level bacterial presences.


"The specific ratio of the three probiotic bacteria was decided based on the relative abundance of these species naturally present in the healthy Chinese population. We previously found that the relative abundance of several species, including B adolescentis and B longum, and the bacterial pathway of short-chain fatty acid production, were all significantly lower in the gut of COVID-19 patients compared with healthy individuals"
...
"Using our metagenomics dataset, we found that B adolescentis, B bifidum, and B longum were the species that had the greatest positive correlations with the relative abundance of short-chain fatty acid-producing bacterial species, which could potentially boost immunity and prevent and treat respiratory infections (unpublished)."

So if the analysis was done at the species level then the exact strains must have been obtained from a healthy individual, but I haven't seen any info on how they decided to select the strains specifically from amongst the species.
 
Last edited:

godlovesatrier

Senior Member
Messages
2,554
Location
United Kingdom
Good digging. Yeah it's very vague but interesting. Ken did try to get human intestinal species and tried those but still saw no colonisation. But maybe these do work who knows. It's a very tricky business colonisation.